Loading…
Accretion Pharmaceuticals (ACCPL)₹203.15−3.26%Pharmaceuticals
At the end of the Jun 2026 quarter, Accretion Pharmaceuticals' shareholders were: promoters 73.49%, DIIs 2.75%, public 23.76%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 775 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Promoters | 73.47% | 73.49% | 73.49% | 73.49% | 73.49% |
| FIIs | 2.24% | 1.17% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.09% | 0.00% | 0.00% | 0.00% | 2.75% |
| Public | 24.20% | 25.34% | 26.51% | 26.51% | 23.76% |
| Promoter shares pledged | — | — | — | — | 0.00% |
| Number of shareholders | 1,627 | 1,497 | 1,178 | 1,181 | 775 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Hardik Mukundbhai Prajapati | Promoter | 17.74% | 0.00 |
| Mayur Popatlal Sojitra | Promoter | 17.72% | 0.00 |
| Vivek Ashok Kumar Patel | Promoter | 17.72% | 0.00 |
| Harshad Nanubhai Rathod | Promoter | 17.65% | 0.00 |
| Unicorn Fund | DII | 2.74% | New |
| Ankita Vivek Patel | Promoter | 0.68% | 0.00 |
| Shweta Sojitra | Promoter | 0.68% | 0.00 |
| Vaishaki Hardik Prajapati | Promoter | 0.68% | 0.00 |
| Pooja Harshad Rathod | Promoter | 0.67% | 0.00 |
| Rekhaben Karshandas Ghetiya | Promoter | 0.02% | 0.00 |
| Rajindra Valsalan | Public | Exited | — |
Promoters held 73.49% of Accretion Pharmaceuticals at the end of the Jun 2026 quarter, up 0.02 percentage points from 73.47% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 2.75% (up 2.75 percentage points from 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Accretion Pharmaceuticals had 775 shareholders at the end of the Jun 2026 quarter, against 1,627 a year earlier.
Unicorn Fund (DII) held 2.74% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.